TRxADE HEALTH, INC. Files 8-K for Asset Acquisition/Disposition
Ticker: SCNX · Form: 8-K · Filed: Mar 6, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Trxade Health, Inc (SCNX) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $8.00, $5.0 million, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, acquisition, disposition, corporate-action
TL;DR
TRxADE HEALTH just filed an 8-K for an asset deal on Feb 29th. Big moves happening.
AI Summary
On February 29, 2024, TRxADE HEALTH, INC. entered into a Material Definitive Agreement related to the completion of an acquisition or disposition of assets. The filing also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for TRxADE HEALTH, INC., potentially involving a major change in its asset base or business operations.
Risk Assessment
Risk Level: medium — The filing pertains to a material definitive agreement and asset acquisition/disposition, which can introduce significant business and financial risks.
Key Players & Entities
- TRxADE HEALTH, INC. (company) — Registrant
- February 29, 2024 (date) — Date of earliest event reported
FAQ
What specific type of Material Definitive Agreement was entered into by TRxADE HEALTH, INC.?
The filing indicates a Material Definitive Agreement related to the completion of an acquisition or disposition of assets, but the specific details of the agreement are not provided in this summary.
What is the significance of the 'Completion of Acquisition or Disposition of Assets' item in this 8-K filing?
This item signifies that TRxADE HEALTH, INC. has completed a transaction involving the acquisition or sale of assets, which could materially impact the company's financial position and operations.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 29, 2024.
What is the primary business of TRxADE HEALTH, INC. according to the filing?
According to the filing, TRxADE HEALTH, INC. is in the business of WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES, with the Standard Industrial Classification code 5122.
What are the former names of TRxADE HEALTH, INC. mentioned in the filing?
The filing lists former names including TRXADE GROUP, INC. (name changed Feb 7, 2014), XCELLINK INTERNATIONAL INC. (name changed Dec 30, 2008), and Bluebird Exploration Co. (name changed Dec 4, 2006).
Filing Stats: 881 words · 4 min read · ~3 pages · Grade level 9.3 · Accepted 2024-03-06 08:30:31
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share MEDS The Nasdaq Stock Mar
- $8.00 — special cash dividend of eight dollars ($8.00) per share of common stock, payable to
- $5.0 million — equal tranches, invest a total of up to $5.0 million in Lafayette in exchange for up to 2,00
- $1.00 — r. The purchase price for the Stock was $1.00 which was delivered to the Company at t
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex10-1.htm (EX-10.1) — 120KB
- ex10-2.htm (EX-10.2) — 90KB
- ex99-1.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 21KB
- 0001493152-24-008947.txt ( ) — 501KB
- meds-20240229.xsd (EX-101.SCH) — 3KB
- meds-20240229_lab.xml (EX-101.LAB) — 33KB
- meds-20240229_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: March 6, 2024